BlackRock Fund Advisors’s Halozyme HALO Stock Holding History

BlackRock Fund Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$50.3M	Buy	5,091,303 +573,105	+13%	+$6.28M	0.01%	1685
2016 Q3	$54.6M	Buy	4,518,198 +165,980	+4%	+$1.7M	0.01%	1512
2016 Q2	$37.6M	Buy	4,352,218 +49,489	+1%	+$488K	0.01%	1683
2016 Q1	$40.7M	Buy	4,302,729 +104,120	+2%	+$980K	0.01%	1574
2015 Q4	$72.8M	Sell	4,198,609 -238,903	-5%	-$3.81M	0.02%	1216
2015 Q3	$59.6M	Buy	4,437,512 +238,383	+6%	+$4.79M	0.02%	1297
2015 Q2	$94.8M	Sell	4,199,129 -4,716	-0.1%	-$82.9K	0.02%	1040
2015 Q1	$60M	Buy	4,203,845 +101,072	+2%	+$1.46M	0.01%	1395
2014 Q4	$39.6M	Buy	4,102,773 +345,340	+9%	+$3.07M	0.01%	1617
2014 Q3	$34.2M	Buy	3,757,433 +1,806	+0%	+$17.2K	0.01%	1605
2014 Q2	$37.1M	Sell	3,755,627 -203,074	-5%	-$1.72M	0.01%	1606
2014 Q1	$50.3M	Buy	3,958,701 +437,810	+12%	+$6.5M	0.01%	1413
2013 Q4	$52.8M	Sell	3,520,891 -4,557	-0.1%	-$58.6K	0.02%	1359
2013 Q3	$38.9M	Buy	3,525,448 +467,133	+15%	+$3.89M	0.01%	1518
2013 Q2	$24.3M	Buy	+3,058,315	New	+$19.5M	0.01%	1709

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock Fund Advisors's HALO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Halozyme (HALO) stake by 13% in Q4 2016, buying an estimated $6.28M and bringing the position to 5,091,303 shares worth $50.3M. The position accounts for 0.01% of the portfolio, ranked #1685.

BlackRock Fund Advisors first reported a position in HALO in Q2 2013 and has held it in 15 quarters since. The position peaked at $94.8M in Q2 2015. 168 funds tracked by Wall St. Rank hold HALO as of Q4 2016.

BlackRock Fund Advisors held 5,091,303 shares of Halozyme worth $50.3M as of Q4 2016.
BlackRock Fund Advisors bought 573,105 Halozyme shares in Q4 2016, an estimated $6.28M.
Halozyme made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1685 holding.
BlackRock Fund Advisors first reported a position in Halozyme in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Halozyme position peaked at $94.8M in Q2 2015.
168 funds tracked by Wall St. Rank held Halozyme as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.